Cornea

Rani Al Karmi selected as 2017 Alcon Research Scholar

July 14, 2017

Rani N. Al Karmi, MD, FRCS(c), M.Ed, a research and clinical fellow in Cornea and External Disease at Mass. Eye and Ear, was selected as the 2017 Alcon Research Scholar. This award provides support to a trainee to allow them to work on a translational research project with a senior clinician scientist at Mass. Eye and Ear. Dr. Al Karmi will work with Reza Dana, MD, MSc, MPH

Read more about Rani Al Karmi selected as 2017 Alcon Research Scholar
Congressional briefing on dry eye disease to be held on July 12

Congressional briefing on dry eye disease to be held on July 12

July 5, 2017

The Tear Film & Ocular Surface Society (TFOS) and the Alliance for Eye and Vision Research (AEVR) will co-host a Congressional briefing about dry eye disease on July 12. Janine Clayton, MD (National Institutes of Health), Susan Vitale, PhD, MHS (National Eye Institute), Anat Galor, MD (Bascom Palmer), Victor Perez, MD (Duke University as of August 2017), Carolyn Begley, OD, MS (Indiana University) and Laura Periman, MD (Redmond Eye Clinic, Seattle), will be joining

Read more about Congressional briefing on dry eye disease to be held on July 12
kathryn hatch performing sugery

Mass. Eye and Ear specialists perform first SMILE procedures to correct nearsightedness

June 16, 2017

Ophthalmologists at Mass. Eye and Ear among most experienced nationwide to offer newly FDA-approved laser vision correction technology.

Boston, Mass. — Ophthalmologists at Massachusetts Eye and Ear are now offering a new type of minimally-invasive laser vision correction, the ReLEx® SMILE procedure. FDA-approved in 2016, and with more than 750,000 procedures performed worldwide each year, SMILE is a proven laser procedure for the treatment of myopia (nearsightedness). Mass. Eye and Ear specialists are

Read more about Mass. Eye and Ear specialists perform first SMILE procedures to correct nearsightedness
reza dana headshot

New technique may prevent graft rejection in high-risk corneal transplant patients

May 1, 2017

Treating donor tissue with a special cocktail of molecules improves outcomes and promotes survival of high-risk corneal transplants

Boston, Mass. — Treating donor corneas with a cocktail of molecules prior to transplanting to a host may improve survival of grafts and, thus, outcomes in high-risk corneal transplant patients, according to a new study led by researchers at Massachusetts Eye and Ear. The findings, 

Read more about New technique may prevent graft rejection in high-risk corneal transplant patients
Researchers identify mechanism of retina damage following chemical eye burns

Researchers identify mechanism of retina damage following chemical eye burns

April 13, 2017

Findings may lead to the development of therapies to prevent damage to the retina, the light-sensitive tissue at the back of the eye.

Boston, Mass. — Chemical eye burns caused by alkali agents not only injure the front of the eye — the cornea, where the contact takes place —  but also cause widespread damage to the light-sensitive tissue at the back of the eye (the retina) as well, often leading to optic nerve damage and glaucoma. In a report

Read more about Researchers identify mechanism of retina damage following chemical eye burns
Deborah Langston Becomes First to Receive Three Highest Honors in the Field of Cornea

Deborah Langston Becomes First to Receive Three Highest Honors in the Field of Cornea

October 14, 2016

Deborah Pavan-Langston, MD, FACS—Harvard Ophthalmology alumna and Professor Emeritus—received the Claes Dohlman Society Award at the Cornea Society/Eye Bank Association of America 2016 Fall Educational Symposium. This lifetime achievement award recognizes her excellence in teaching and contributions to the field of cornea and external disease. 

Dr. Langston is the first person to receive all three of the highest honors in cornea: the Castroviejo Medal for Outstanding Contributions to the Field of Corneal and Anterior Segment Disease (American Academy of Ophthalmology), the

Read more about Deborah Langston Becomes First to Receive Three Highest Honors in the Field of Cornea
Researchers find proliferating cells in normal and diseased corneal endothelium

Researchers find proliferating cells in normal and diseased corneal endothelium

September 14, 2016

Findings published in the American Journal of Pathology offer new directions for treatment of patients with Fuchs’ Endothelial Corneal Dystrophy (FECD)

Boston, Mass. —  Researchers from Massachusetts Eye and Ear have, for the first time, identified rapidly proliferating cells (known as “neural crest-derived progenitor cells”) in the corneal endothelium of specimens from normal corneas and from corneas with Fuchs’ Endothelial Corneal Dystrophy (FECD), a condition in which the cells responsible for keeping the cornea

Read more about Researchers find proliferating cells in normal and diseased corneal endothelium
Inflammatory Factors Cause Damage to Back of Eye Following Keratoprosthesis Implantation

Inflammatory Factors Cause Damage to Back of Eye Following Keratoprosthesis Implantation

April 7, 2016

Researchers at Massachusetts Eye and Ear/Harvard Medical School have identified inflammatory factors that contribute to optic nerve damage following keratoprosthesis (KPro) implantation in a mouse model. They have also shown that blocking one of the factors, TNFa, leads to a significant decrease in optic nerve cell death, suggesting a new direction for preventing optic nerve damage in patients with keratoprosthesis implants.

BOSTON – Researchers from

Read more about Inflammatory Factors Cause Damage to Back of Eye Following Keratoprosthesis Implantation